Diagnostic Accuracy of DaTQUANT® Versus BasGanV2™ for 123I-Ioflupane Brain SPECT: A Machine Learning-Based Differentiation of Parkinson’s Disease and Essential Tremor
<b>Background</b>: Differentiating Parkinson's disease (PD) from essential tremor (ET) is often challenging, especially in early or atypical cases. Dopamine transporter (DAT) single-photon emission computed tomography (SPECT) with <sup>123</sup>I-Ioflupane supports diagnosis, and semi-quantitative tools such as DaTQUANT<sup>®</sup> and BasGanV2™ provide objective measures. This study compared their diagnostic performance when integrated with supervised machine learning. <b>Methods</b>: We retrospectively analysed <sup>123</sup>I-Ioflupane SPECT scans from 169 patients (133 PD, 36 ET). Semi-quantitative analysis was performed using DaTQUANT<sup>®</sup> v2.0 and BasGanV2™ v.2. Classification tree (ClT), k-nearest neighbour (k-NN), and support vector machine (SVM) models were trained and validated with stratified shuffle split (250 iterations). Diagnostic accuracy was compared between the two software packages. <b>Results</b>: All classifiers reliably distinguished PD from ET. DaTQUANT<sup>®</sup> consistently achieved higher accuracy than BasGanV2™: 93.8%, 93.2%, and 94.5% for ClT, k-NN, and SVM, respectively, versus 90.9%, 91.7%, and 91.9% for BasGanV2™ (<i>p</i> < 0.001). Sensitivity and specificity were also consistently higher for DaTQUANT<sup>®</sup> than BasGanV2. Class imbalance (PD > ET) was addressed using Synthetic Minority Over-sampling Technique (SMOTE). <b>Conclusions</b>: Machine learning analysis of <sup>123</sup>I-Ioflupane SPECT enhances differentiation between PD and ET. DaTQUANT<sup>®</sup> outperformed BasGanV2™, suggesting greater suitability for AI-driven decision support. These findings support the integration of semi-quantitative and AI-based approaches into clinical workflows and highlight the need for harmonised methodologies in movement disorder imaging.
Authors
- Viviana Frantellizzi (ORCID: https://orcid.org/0000-0003-3497-4236)
- Francesco Bianconi (ORCID: https://orcid.org/0000-0003-3371-1928)
- Susanna Nuvoli (ORCID: https://orcid.org/0000-0002-7194-985X)
- Angela Spanu (ORCID: https://orcid.org/0000-0001-5753-399X)
- Giuseppe De Vincentis (ORCID: https://orcid.org/0000-0003-4690-1528)
- Luca Filippi (ORCID: https://orcid.org/0000-0003-4423-5496)
- Andrea Marongiu (ORCID: https://orcid.org/0000-0001-7038-3615)
- Mario Luca Fravolini (ORCID: https://orcid.org/0000-0002-3104-8782)
- Barbara Palumbo (ORCID: https://orcid.org/0000-0003-2475-343X)
- Roberta Danieli (ORCID: https://orcid.org/0000-0002-5172-1508)
Institutions
- University of Rome Tor Vergata (IT)
- Vita-Salute San Raffaele University (IT)
- University of Sassari (IT)
- University of Perugia (IT)
- Azienda Ospedaliera di Perugia (IT)
- IRCCS Ospedale San Raffaele (IT)
- Sapienza University of Rome (IT)
Publication Details
- Journal
- Biomedicines
- Published
- 2025-09-27
- DOI
- https://doi.org/10.3390/biomedicines13102367
- Primary Topic
- Neurological disorders and treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00